The effects of oestrogens and their receptors on cardiometabolic health (Q38901474)

7 September 2017

title

The effects of oestrogens and their receptors on cardiometabolic health (English)

1 reference

7 September 2017

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304393%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

6

Deborah J Clegg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304393%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

5

Biff F Palmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304393%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1

Eugenia Morselli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304393%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Roberta S Santos

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304393%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Alfredo Criollo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304393%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

1 reference

17 March 2017

1 reference

Nature Reviews Endocrinology

7 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304393%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304393%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304393%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

352-364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304393%20AND%20SRC:MED&resulttype=core&format=json

Clinical cardiovascular studies of hormone replacement therapy

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Gender differences in coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Androgens and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Cardiovascular disease and androgens: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Sex and Gender: Critical Variables in Pre-Clinical and Clinical Medical Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Sex Hormones and Their Receptors Regulate Liver Energy Homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Timing of estrogen replacement influences atherosclerosis progression and plaque leukocyte populations in ApoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Type and route of estrogen administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Metabolic effects of oral versus transdermal 17β-estradiol (E₂): a randomized clinical trial in girls with Turner syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen--the good, the bad, and the unexpected.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

The role of estrogens in control of energy balance and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Aromatase Deficiency Confers Paradoxical Postischemic Cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Aromatase inhibition attenuates desflurane-induced preconditioning against acute myocardial infarction in male mouse heart in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

17alpha-estradiol: a brain-active estrogen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Dietary exposure of 17-alpha ethinylestradiol modulates physiological endpoints and gene signaling pathways in female largemouth bass (Micropterus salmoides).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Review of the effects of 17α-estradiol in humans: a less feminizing estrogen with neuroprotective potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

17α-estradiol is generated locally in the male rat brain and can regulate GAD65 expression and anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen and the brain: beyond ER-alpha, ER-beta, and 17beta-estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

17α-Estradiol Alleviates Age-related Metabolic and Inflammatory Dysfunction in Male Mice Without Inducing Feminization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Obesity, estrone, and coronary artery disease in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estriol retards and stabilizes atherosclerosis through an NO-mediated system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen receptor alpha and beta in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Lessons from the dissection of the activation functions (AF-1 and AF-2) of the estrogen receptor alpha in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Mechanisms of Action of Steroid Hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Metabolic impact of estrogen signalling through ERalpha and ERbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen signaling in metabolic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Plasma membrane estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen receptor alpha up-regulation and redistribution in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Immunolocalisation of oestrogen receptor beta in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen effects on vascular inflammation are age dependent: role of estrogen receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Increased adipose tissue in male and female estrogen receptor-alpha knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen receptor-alpha mediates acute myocardial protection in females

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

The estrogen receptor-α is required and sufficient to maintain physiological glucose uptake in the mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: functional, metabolic, and differential network analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Cardiomyocyte-specific Estrogen Receptor Alpha Increases Angiogenesis, Lymphangiogenesis and Reduces Fibrosis in the Female Mouse Heart Post-Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Expression, distribution and regulation of sex steroid hormone receptors in mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

The Role of Estrogen and Estrogen Receptors on Cardiomyocytes: An Overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

The G-protein-coupled estrogen receptor GPER in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Evidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen, hormonal replacement therapy and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Risk factors for myocardial infarction in women and men: insights from the INTERHEART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Ovarian dysfunction and the premenopausal origins of coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Premature menopause increases cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Risk factors for coronary heart disease: implications of gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Cardiovascular diseases in American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Long-term health consequences of premature or early menopause and considerations for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Menopause and risk of cardiovascular disease: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Low-dose estrogen supplementation improves vascular function in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Association between estrogen receptor alpha gene variation and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen receptor alpha gene variation and the risk of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Association of an estrogen receptor-alpha gene polymorphism with left ventricular mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Association of the estrogen receptor-alpha gene with the metabolic syndrome and its component traits in African-American families: the Insulin Resistance Atherosclerosis Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen receptor beta gene variants may be associated with more favorable metabolic profile in postmenopausal women undergoing coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

The association between the rs2234693 and rs9340799 estrogen receptor alpha gene polymorphisms and risk factors for cardiovascular disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen receptor alpha interacts with 17beta-hydroxysteroid dehydrogenase type 10 in mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Functional estrogen receptors in the mitochondria of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen actions on mitochondria--physiological and pathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Caloric restriction and gender modulate cardiac muscle mitochondrial H2O2 production and oxidative damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen suppresses brain mitochondrial oxidative stress in female and male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Mitochondrial oxidant generation is involved in determining why females live longer than males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

17β-estradiol prevents cardiac diastolic dysfunction by stimulating mitochondrial function: a preclinical study in a mouse model of a human hypertrophic cardiomyopathy mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Type II diabetes mellitus and menopause: a multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Menopause and risk of diabetes in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause: longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

The effect of the menopausal transition on body composition and cardiometabolic risk factors: a Montreal-Ottawa New Emerging Team group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen Signaling and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Na+K+-ATPase activity and K+ channels differently contribute to vascular relaxation in male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Molecular and cellular basis of cardiovascular gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Genomic and nongenomic effects of estrogen in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen receptors and endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Non-nuclear estrogen receptor signaling in the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

17-β Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1/AMPK/H3 acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

SIRT1 functions as an important regulator of estrogen-mediated cardiomyocyte protection in angiotensin II-induced heart hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

MiR-22/Sp-1 Links Estrogens With the Up-Regulation of Cystathionine γ-Lyase in Myocardium, Which Contributes to Estrogenic Cardioprotection Against Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Obesity accelerates the progression of coronary atherosclerosis in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estradiol inhibits vascular endothelial cells pro-inflammatory activation induced by C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

17beta-estradiol affects in vivo the low density lipoprotein composition, particle size, and oxidizability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Regulation of endothelial nitric oxide synthase and high-density lipoprotein quality by estradiol in cardiovascular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen, aging and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Hypothalamic PGC-1α protects against high-fat diet exposure by regulating ERα.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Metabolic impact of sex hormones on obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen as an immunomodulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

A sexually dimorphic hypothalamic response to chronic high-fat diet consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Adverse events associated with testosterone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Testosterone and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Acute anti-ischemic effect of testosterone in men with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Elevated t/e2 ratio is associated with an increased risk of cerebrovascular disease in elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Low serum testosterone and estradiol predict mortality in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Sexual Dimorphism in Mammalian Autosomal Gene Regulation Is Determined Not Only by Sry but by Sex Chromosome Complement As Well

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Transgender health in Massachusetts: results from a household probability sample of adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Low Estradiol Concentrations in Men With Subnormal Testosterone Concentrations and Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Age at Natural Menopause and Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen Receptor α Gene Variation Is Associated With Risk of Myocardial Infarction in More Than Seven Thousand Men From Five Cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Association of Estrogen Receptor β Gene Polymorphisms With Left Ventricular Mass and Wall Thickness in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Sex-Specific Association between Estrogen Receptor-α Gene Variation and Measures of Adiposity: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Association between ESR2 Genetic Variants and Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Postmenopausal Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

SEPARATION AND ESTIMATION OF 17-ALPHA-ESTRADIOL

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Concentration of unconjugated estrone and estradiol in peripheral plasma in nonpregnant women throughout the menstrual cycle, castrate and postmenopausal women and in men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Mechanisms of estrogen action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen receptors alpha and beta mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Risk factors that attenuate the female coronary disease advantage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Does age at natural menopause affect mortality from ischemic heart disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

The association of hypotestosteronemia with coronary artery disease in men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

No replication of association between estrogen receptor alpha gene polymorphisms and susceptibility to myocardial infarction in a large sample of patients of European descent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

ESR1 genetic variants, haplotypes and the risk of coronary heart disease and ischemic stroke in the Finnish population: a prospective follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Independent association between age at natural menopause and hypercholesterolemia, hypertension, and diabetes mellitus: Japan nurses' health study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Estradiol/Testosterone Imbalance: Impact on Coronary Heart Disease Risk Factors in Postmenopausal Women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2017.12

Deaths: final data for 2010.

31 March 2020

1 reference

12 December 2020

The Coronary Drug Project. Initial findings leading to modifications of its research protocol

1 reference

12 December 2020

Regulation of Estrogen Receptor α Expression in the Hypothalamus by Sex Steroids: Implication in the Regulation of Energy Homeostasis

1 reference

12 December 2020

Gender differences in cardiovascular disease and comorbid depression

1 reference

12 December 2020

The influence of estradiol on nervous system function

1 reference

12 December 2020

Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies

1 reference

12 December 2020

Estrogen signaling in the cardiovascular system

1 reference

12 December 2020

Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study

1 reference

12 December 2020

Clinical review 91: Female sex hormones and cardiovascular disease in women

1 reference

12 December 2020

Bilateral oophorectomy may have an unfavorable effect on glucose metabolism compared with natural menopause.

1 reference

12 December 2020

Long-term prospective study of the influence of estrone levels on events in postmenopausal women with or at high risk for coronary artery disease.

1 reference

12 December 2020

Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology

1 reference

12 December 2020

Direct colorimetric monoclonal antibody enzyme immunoassay for estradiol-17 beta in saliva

1 reference

12 December 2020

Cellular Receptors and Mechanisms of Action of Steroid Hormones

1 reference

12 December 2020

Chronic High Fat Diet Consumption Impairs Metabolic Health of Male Mice

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2017.12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304393%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference